Tactile Systems Technology, Inc. (NASDAQ:TCMD) COO Robert J. Folkes sold 1,500 shares of the stock in a transaction on Wednesday, July 12th. The shares were sold at an average price of $29.49, for a total value of $44,235.00. Following the completion of the sale, the chief operating officer now owns 129,837 shares of the company’s stock, valued at approximately $3,828,893.13. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Tactile Systems Technology, Inc. (NASDAQ TCMD) traded down 1.87% during mid-day trading on Monday, hitting $29.44. The stock had a trading volume of 26,361 shares. The company has a market cap of $498.71 million and a P/E ratio of 265.23. Tactile Systems Technology, Inc. has a 1-year low of $10.00 and a 1-year high of $31.49. The company has a 50-day moving average price of $27.59 and a 200 day moving average price of $20.69.
Tactile Systems Technology (NASDAQ:TCMD) last announced its quarterly earnings results on Monday, May 8th. The company reported ($0.09) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.14) by $0.05. Tactile Systems Technology had a net margin of 2.24% and a return on equity of 4.82%. The company had revenue of $19.85 million during the quarter, compared to analyst estimates of $16.17 million. During the same quarter in the previous year, the business earned ($0.45) EPS. The firm’s revenue was up 44.9% on a year-over-year basis. Equities research analysts forecast that Tactile Systems Technology, Inc. will post $0.13 EPS for the current fiscal year.
WARNING: This piece was first published by Transcript Daily and is the property of of Transcript Daily. If you are accessing this piece on another site, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this piece can be accessed at https://transcriptdaily.com/2017/07/24/tactile-systems-technology-inc-nasdaqtcmd-coo-sells-44235-00-in-stock.html.
Separately, Zacks Investment Research upgraded Tactile Systems Technology from a “hold” rating to a “buy” rating and set a $24.00 target price for the company in a report on Thursday, May 11th. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average target price of $24.25.
Institutional investors have recently made changes to their positions in the company. Bank of New York Mellon Corp raised its position in shares of Tactile Systems Technology by 33.7% in the first quarter. Bank of New York Mellon Corp now owns 13,805 shares of the company’s stock worth $262,000 after buying an additional 3,480 shares during the last quarter. Bank of Montreal Can bought a new position in shares of Tactile Systems Technology during the second quarter worth $146,000. Bank of America Corp DE raised its position in shares of Tactile Systems Technology by 1,118.5% in the first quarter. Bank of America Corp DE now owns 6,982 shares of the company’s stock worth $133,000 after buying an additional 6,409 shares during the last quarter. EAM Investors LLC raised its position in shares of Tactile Systems Technology by 15.4% in the first quarter. EAM Investors LLC now owns 70,449 shares of the company’s stock worth $1,335,000 after buying an additional 9,383 shares during the last quarter. Finally, Geode Capital Management LLC raised its position in shares of Tactile Systems Technology by 17.2% in the first quarter. Geode Capital Management LLC now owns 70,704 shares of the company’s stock worth $1,339,000 after buying an additional 10,377 shares during the last quarter. 29.93% of the stock is owned by hedge funds and other institutional investors.
Tactile Systems Technology Company Profile
Tactile Systems Technology, Inc is a medical technology company that develops and provides medical devices for the treatment of chronic diseases at home. The Company is a manufacturer and distributor of the Flexitouch and Entre Systems, medical devices that help control symptoms of lymphedema, a chronic and progressive medical condition that is often an unintended consequence of cancer treatment, and the ACTitouch System, a medical device used to treat venous leg ulcers and chronic venous insufficiency.
Receive News & Ratings for Tactile Systems Technology Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tactile Systems Technology Inc. and related companies with MarketBeat.com's FREE daily email newsletter.